Syndex Bio
PrivateLast Round
Seed
Feb 23, 2026
Total Funding Raised
$15.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Syndex Bio operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Seed round in February 2026.
Syndex Bio is a biotechnology company developing a platform that brings together molecular technologies, instrumentation, and AI to accelerate the understanding, diagnosis, and treatment of disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syndex Bio Comparables
Compare Syndex Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Epinoma | 85% | |
| Epigentek Group Inc. | 69% | |
| biomodal | 69% |
For institutional investors. Book with your work email.
Syndex Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Syndex Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| +ND Capital | Seed |
| Meltwind Advisory | Seed |
| ARCH Venture Partners | Seed |
| OMX Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 43% MoM, reaching 1.4K.
- Mar 6, 2026
Grew 28% QoQ, from 18 to 23 employees.
For institutional investors. Book with your work email.
Syndex Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Syndex Bio's valuation, stock price, and market status.
Is Syndex Bio a public or private company?
Syndex Bio is a private company.
What is the current stock price of Syndex Bio?
Syndex Bio is a private company, so its shares have no public market price. Caplight tracks Syndex Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Syndex Bio worth (valuation)?
Valuation information for Syndex Bio is not publicly available.
Can I buy Syndex Bio stock?
Syndex Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Syndex Bio's last funding round?
Syndex Bio's most recent funding round was Seed on February 23, 2026.
Who are the main investors in Syndex Bio?
Key investors in Syndex Bio include ARCH Venture Partners.
Will Syndex Bio IPO soon?
No public IPO plans have been announced for Syndex Bio.
How can I track Syndex Bio secondary market activity?
Caplight tracks bids, offers, and trades in Syndex Bio's shares on secondary markets.